Virtual Reality Therapy provider HypnoVR Acquires Oncomfort

Read also - Paris-based Qobra Secures €10 million Series A Round Funding

Over 550 European healthcare facilities are now using HypnoVR technology, including more than one hundred in Belgium. A total of 200,000 patients have already been treated using its digital therapies that include software and a VR headset.

Read also - Utrecht-based Cordys Analytics Raises €900k in Seed Funding 

The company has the most advanced clinical validation in its field, with more than fifty clinical trials having demonstrated the efficacy of the HypnoVR and Oncomfort therapies to manage pain and anxiety, reduce medication use and improve the care pathway.

Read also - Helsinki-based MeetingPackage Secures $4.6 million in Series A Funding Round

Nicolas Schaettel, president and co-founder of HypnoVR said, “The Oncomfort acquisition is a highly strategic step for HypnoVR that reinforces our position as the European leader in digital therapies to treat pain and anxiety and provides an ever-increasing number of healthcare facilities and patients with access to these advanced technologies. Our vision is one that Oncomfort shares, based on the clinical validity of digital therapeutic solutions and the potential of technology to deliver them to as many people as possible. HypnoVR pioneered the development and roll-out of virtual reality-based medical hypnosis solutions in France and Europe, and we intend to ramp up this work on an international scale,”.

Diane Jooris, founder of Oncomfort said , “Both HypnoVR and Oncomfort are pioneering companies in digital sedation and have been built on shared values, scientific validation and strict adherence to regulations to ensure compliance with the requirements for digital medical devices. I firmly believe that our acquisition by HypnoVR will create worthwhile collaborations to help healthcare professionals go further in adopting this solution as the standard of care for relieving pain and anxiety, benefiting a growing number of patients,” .

About Oncomfort

Oncomfort was founded in 2017 to develop Digital Sedation™, an innovative medical device combining the capabilities of virtual reality with expertise in medical hypnosis. Digital Sedation™ is a CE-marked product designed to offer patients an alternative or supplementary treatment to drugs, for managing pain and anxiety.

Read also - Hungary-based Startup Flawless Secures $2.2 Mn in Seed Funding

About HypnoVR

HypnoVR is a medical device combining the benefits of medical hypnosis with virtual reality. Designed by two anesthesiologists and hypnotists with more than 15 years of experience, HypnoVR has demonstrated its effectiveness in the treatment of pain and anxiety through 15 clinical studies (postoperative length of stay divided by 3.57 and 45% reduction in morphine consumption).

Read also - Lausanne based Debiopharm Innovation Fund Launches $150 million Seed Funding Initiative.

HypnoVR is a simple and quick tool for health professionals, especially those specialized in anesthesia, surgery and dental surgery. It complies with the hygiene standards of health institutions and medical practices: HypnoVR adapts to your care organization with a range of fixed or mobile equipment.

Read also - Barcelona-based Incapto Raises €6 million in Funding